Anticytokine therapy in neuropathic pain management (Q36998861)

17 August 2017

1 reference

title

Anticytokine therapy in neuropathic pain management (English)

1 reference

17 August 2017

0 references

0 references

2

Claudia Sommer

2 references

ORCID Public Data File 2021

17 August 2017

Maria Schäfers

1

1 reference

17 August 2017

1 November 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 August 2017

1 reference

17 August 2017

7

1 reference

17 August 2017

11

1 reference

17 August 2017

1613-1627

1 reference

The extent of cytokine induction in peripheral nerve lesions depends on the mode of injury and NMDA receptor signaling

17 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Increase of interleukin-6 mRNA in the spinal cord following peripheral nerve injury in the rat: potential role of IL-6 in neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Cytokine and growth factor immunohistochemical spinal profiles in two animal models of mononeuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Nerve root injury severity differentially modulates spinal glial activation in a rat lumbar radiculopathy model: considerations for persistent pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Thermal hyperalgesia and mechanical allodynia produced by intrathecal administration of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein, gp120.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Interleukin-6 and nerve growth factor levels in peripheral nerve and brainstem after trigeminal nerve injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Expression of IL-1beta in supraspinal brain regions in rats with neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Antinociception mediated by alpha(2)-adrenergic activation involves increasing tumor necrosis factor alpha (TNFalpha) expression and restoring TNFalpha and alpha(2)-adrenergic inhibition of norepinephrine release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Brain-derived TNFalpha mediates neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Pentoxifylline attenuates the development of hyperalgesia in a rat model of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Nociceptive and inflammatory effects of subcutaneous TNFalpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Pain modulatory actions of cytokines and prostaglandin E2 in the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

IL-1 beta potentiates heat-activated currents in rat sensory neurons: involvement of IL-1RI, tyrosine kinase, and protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Contribution of interleukin‐1β to the inflammation‐induced increase in nerve growth factor levels and inflammatory hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Dorsal root sensitivity to interleukin-1 beta, interleukin-6 and tumor necrosis factor in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Role of TNF-alpha in sensitization of nociceptive dorsal horn neurons induced by application of nucleus pulposus to L5 dorsal root ganglion in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

TNF receptor subtype signalling: differences and cellular consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

TNF-alpha and TNF-alpha receptor type 1 upregulation in glia and neurons after peripheral nerve injury: studies in murine DRG and spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Spinal nerve ligation induces transient upregulation of tumor necrosis factor receptors 1 and 2 in injured and adjacent uninjured dorsal root ganglia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

The role of tumor necrosis factor-alpha in the neuropathic pain induced by Lumbar 5 ventral root transection in rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

TNF-alpha receptors simultaneously activate Ca2+ mobilisation and stress kinases in cultured sensory neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

TNF-alpha and phosphorylation of ERK in DRG and spinal cord: insights into mechanisms of sciatica.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Structural changes of tumor necrosis factor alpha associated with membrane insertion and channel formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Formation of ion-permeable channels by tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-alpha (TNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Amitriptyline administration transforms tumor necrosis factor-alpha regulation of norepinephrine release in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Uncovering molecular elements of brain-body communication during development and treatment of neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Tumor necrosis factor expressed by primary hippocampal neurons and SH-SY5Y cells is regulated by alpha(2)-adrenergic receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Effect of tumor necrosis factor-alpha on the reciprocal G-protein-induced regulation of norepinephrine release by the alpha2-adrenergic receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Algorithm for neuropathic pain treatment: an evidence based proposal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

A nitric oxide (NO)-releasing derivative of gabapentin, NCX 8001, alleviates neuropathic pain-like behavior after spinal cord and peripheral nerve injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Antihyperalgesic efficacy of lacosamide in a rat model for muscle pain induced by TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Neurocircuitry of illness-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Tumor necrosis factor receptor type-1 in sensory neurons contributes to induction of chronic enhancement of inflammatory hyperalgesia in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

A cascade of cytokines mediates mechanical inflammatory hypernociception in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Etanercept reduces hyperalgesia in experimental painful neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Gene transfer to interfere with TNFalpha signaling in neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Nociceptive responses in interleukin-6-deficient mice to peripheral inflammation and peripheral nerve section.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Spinal interleukin-6 (IL-6) inhibits nociceptive transmission following neuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Central proinflammatory cytokines and pain enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

HSV-mediated expression of interleukin-4 in dorsal root ganglion neurons reduces neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Evidence for endogenous interleukin-10 during nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-alpha expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐10

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Interleukin-2 gene therapy of chronic neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Adenovirus-mediated interleukin-2 gene therapy of nociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Sciatic nerve ligation-induced proliferation of spinal cord astrocytes is mediated by kappa opioid activation of p38 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Differential expression of cytokines in painful and painless neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Successful treatment with low-dose thalidomide in a patient with both Behçet's disease and complex regional pain syndrome type I: case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Successful treatment of CRPS 1 with anti-TNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Intermediate stage complex regional pain syndrome type 1 is unrelated to proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Interleukin-2: a potential treatment option for postherpetic neuralgia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Proinflammatory cytokines in cerebrospinal fluid and serum in patients with disc herniation and sciatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

The treatment of disc-herniation-induced sciatica with infliximab: one-year follow-up results of FIRST II, a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Glia: a novel drug discovery target for clinical pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Gene therapy applications for the treatment of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Role of lipocortin-1 in the anti-hyperalgesic actions of dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Analgesic effect of thalidomide on inflammatory pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Effects of selective tumor necrosis factor-alpha inhibition to pain-behavioral changes caused by nucleus pulposus-induced damage to the spinal nerve in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor alpha soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

IL-4 gene therapy for collagen arthritis suppresses synovial IL-17 and osteoprotegerin ligand and prevents bone erosion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11.1613

10.1586/14737175.7.11.1613

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17997707